Serotonin, the periaqueductal gray and panic

被引:205
作者
Graeff, FG [1 ]
机构
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Programa Saude Menta, Dept Neurol Psychiat & Med Psychol, BR-14025000 Ribeirao Preto, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
animal models of anxiety; human experimental anxiety; serotonin modulation of defense; neurobiology of panic disorder;
D O I
10.1016/j.neubiorev.2003.12.004
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
This article reviews experimental evidence and theoretical constructs that implicate serotonin (5-HT) modulation of defensive behavior within the midbrain periaqueductal gray in panic disorder (PD). Evidence with conflict tests in experimental animals indicates that 5-HT enhances anxiety, whereas results with aversive stimulation of the dorsal periaqueductal gray point to an anxiolytic role of 5-HT. To solve this contradiction, it has been suggested that the emotional states determined by the two types of animal model are different. Conflict tests would generate conditioned anxiety, whereas periaqueductal gray stimulation would produce unconditioned fear, as evoked by proximal threat. Clinically, the former would be related to generalized anxiety while the latter to PD. Thus, 5-HT is supposed to facilitate anxiety, but to inhibit panic. This hypothesis has been tested in the animal model of anxiety and panic named the elevated T-maze, in two procedures of human experimental anxiety applied to healthy volunteers or panic patients, and in CO2-induced panic attacks. Overall, the obtained results have shown that drugs that enhance 5-HT function increase different indexes of anxiety, but decrease indexes of panic. Drugs that impair 5-HT function have the opposite effects. Thus, so far the predictions derived from the above hypothesis have been fulfilled. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:239 / 259
页数:21
相关论文
共 144 条
[1]   Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei [J].
Adell, A ;
Celada, P ;
Abellán, MT ;
Artigas, F .
BRAIN RESEARCH REVIEWS, 2002, 39 (2-3) :154-180
[2]  
ADLER CM, 1987, INTEGRATIVE PSYCHIAT, V5, P94
[3]  
American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT, P5
[4]  
Andrade T. G. C. S., 2000, Journal of Psychopharmacology, V14, pA38
[5]  
ANDRADE TGC, 2004, IN PRESS BEHAV BRAIN
[6]  
[Anonymous], 1959, STANDARD EDITION COM
[7]  
[Anonymous], HDB ANXIETY
[8]   The psychobiology of anxiolytic drugs - Part 2: pharmacological treatments of anxiety [J].
Argyropoulos, SV ;
Sandford, JJ ;
Nutt, DJ .
PHARMACOLOGY & THERAPEUTICS, 2000, 88 (03) :213-227
[9]   MICROINJECTION OF PROPRANOLOL INTO THE DORSAL PERIAQUEDUCTAL GRAY CAUSES AN ANXIOLYTIC EFFECT IN THE ELEVATED PLUS-MAZE ANTAGONIZED BY RITANSERIN [J].
AUDI, EA ;
DEOLIVEIRA, RMW ;
GRAEFF, FG .
PSYCHOPHARMACOLOGY, 1991, 105 (04) :553-557
[10]   AUTORADIOGRAPHIC ANALYSIS OF DIFFERENTIAL ASCENDING PROJECTIONS OF DORSAL AND MEDIAN RAPHE NUCLEI IN RAT [J].
AZMITIA, EC ;
SEGAL, M .
JOURNAL OF COMPARATIVE NEUROLOGY, 1978, 179 (03) :641-667